Shai Ran Sapir, Ph.D., MBA, is the Cardiovascular Portfolio Manager at Mayo Clinic Ventures. Mayo Clinic Ventures serves as both the technology transfer office for Mayo Clinic—handling IP licensing, new company formation, know-how agreements, joint development—and Mayo Clinic’s investment arm. It bridges the gap from ideation to commercialization internally and invests externally in companies collaborating with Mayo Clinic to enhance patient care globally.

Dr. Ran Sapir plays a crucial role in the commercialization of IP developed under Mayo Clinic's Cardiovascular Medicine Division. His responsibilities include identifying promising intellectual property from Mayo Clinic research, recognizing gaps in the market where Mayo Clinic’s innovations can improve care, negotiating various deal structures, and presenting investment opportunities to the appropriate investment committees within Mayo.

Since joining Mayo Clinic Ventures in 2022, Dr. Ran Sapir has successfully orchestrated numerous licensing agreements, new company formations, strategic alliances, and conducted due diligence on a wide range of investments within the cardiovascular vertical.

Dr. Ran Sapir holds a Ph.D. in Molecular Biology from Tel Aviv University and an MBA from the Coller School of Management at Tel Aviv University.